alexa Survival Outcomes of Surgical Resection of Metastasis t
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Survival Outcomes of Surgical Resection of Metastasis to the Breast from Extra-Mammary Malignancies: An Individual Patient Data Analysis

 
To read the full article Peer-reviewed Article PDF image

Abstract

Abstract Background: It remains unclear whether surgical resection of in-breast metastasis from extra mammary malignancies would improve survival. Methods: There were 29 cases including 25 cases reported by 24 studies and 4 unreported cases from PUMC Hospital in this individual patient data (IPD) meta-analysis. The clinic pathological characteristics and overall survival (OS) were compared. The subgroup of patients who might potentially benefit from surgical resection of the metastatic lesion to the breast was identified. Results: The breast symptoms were 22 lumps (75.9%), 4 huge mass (13.8%), 3 inflammatory changes (10.3%), 1 ulceration (3.4%) and 1 non-palpable lesion (3.4%). There were 2 male patients (6.9%) with breast metastasis and 3 female patients (10.3%) with bilateral breast metastasis. The primary malignancy sites included 10 gastrointestinal (34.5%), 7 lung (24.1%), 4 urogenital (13.8%) and 3 trunk and limbs (10.3%). Adenocarcinoma (48.3%) was the commonest pathology. Twelve patients (41.4%) had metastases only to the breast. Seven breast metastases (24.1%) were diagnosed simultaneously with the primary malignancies, and 2 breast metastases (6.9%) were detected before the primary. The 12-month OS rate was 55.2% and the median survival was 5 month (1-60 months). 16 patients (55.2%) received surgical resection of the in-breast metastases, and their OS was not significantly different from those biopsy-only patients. Conclusion: Surgical resection of metastases to the breast from extra-mammary malignancies could achieve similar survival outcome compared to patients who only received core needle biopsy, with potential of improving the quality of life for patients with breast ulceration, huge mass and inflammatory changes.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords